Wouter T. Zandee - Concepedia

Author

Wouter T. Zandee

Also Known As

W T Zandee, W. T. Zandee, W. Zandee, W.T. Zandee, Wouter T Zandee, Wouter T. Zandee, Wouter Zandee, Wouter T. Zandee, Zandee, W., Zandee, W.T.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC University Medical Center Groningen Erasmus MC Cancer Institute University of Groningen Hôpital Beaujon

About

Wouter T. Zandee is an author at Erasmus MC specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	233
2	Pathology	3	3	204
3	Gastroenterology	2	2	182
4	Nutrition	1	1	30
5	Pharmacology	1	1	152

Wouter T. Zandee

Publications

916

Citations

H-Index

Page 1

	Year	Citations
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study Esben Andreas Carlsen, Nicola Fazio, Simona Grozinsky‐Glasberg, Endocrine Related Cancer Gastrointestinal Peptide HormonePancreatic CancerProgressive DiseaseGastrointestinal OncologyGastrointestinal Pharmacology	2018	152
Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors Wouter T. Zandee, Tessa Brabander, Anela Blažević, The Journal of Clinical Endocrinology & Metabolism	2018	132
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study Guido Rindi, Catherine Klersy, Luca Albarello, Neuroendocrinology	2018	102
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE Wouter T. Zandee, Richard A. Feelders, Daan A. Smit Duijzentkunst, European Journal of Endocrinology	2019	76
Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours Anela Blažević, Wouter T. Zandee, Gaston J H Franssen, Endocrine Related Cancer	2017	55
Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome Wouter T. Zandee, Tessa Brabander, Anela Blažević, The Journal of Clinical Endocrinology & Metabolism	2021	53
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours Wouter T. Zandee, Kimberly Kamp, Roxanne C.S. van Adrichem, European Journal of Endocrinology	2016	45
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, The Oncologist	2020	40
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs Louis de Mestier, Ángela Lamarca, Jorge Hernando, Endocrine Related Cancer NutritionGastroenterologyPathologySurgeryDigestive Tract	2021	30
Fewer Cancer Reoperations for Medullary Thyroid Cancer After Initial Surgery According to ATA Guidelines Hans H G Verbeek, Johannes Arnoldus Anthonius Meijer, Wouter T. Zandee, Annals of Surgical Oncology Surgical OncologyAta GuidelinesMedicineFewer Cancer ReoperationsThyroid Disease	2014	29

Page 1